http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6423526-B1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b5d1de0cb099ee72980dadb3b90d66d8 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-6424 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-64 |
filingDate | 2000-11-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2002-07-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_55566043eae1bd031fc6d574cbfddad7 |
publicationDate | 2002-07-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | US-6423526-B1 |
titleOfInvention | Human serine protease |
abstract | Members of the serine protease family play a role in carefully controlled processes, such as blood coagulation, fibrinolysis, complement activation, fertilization, and hormone production. These enzymes are also used in a variety of diagnostic, therapeutic, and industrial contexts. Zfaix1 is a new member of the serine protease family. |
priorityDate | 1999-11-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 269.